Useful resources |
Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease (Cochrane Review) ABSTRACT Background: Long term levodopa therapy in Parkinson's disease is associated with the development of motor complications including abnormal involuntary movements and a shortening response to each dose (wearing off phenomenon). It is thought that dopamine agonists . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |